A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B-Reference-Cited by-同舟云学术

A Randomized, Open-Label Clinical Study of Combined Pegylated Interferon Alfa-2a (40KD) and Entecavir Treatment for Hepatitis B "e" Antigen-Positive Chronic Hepatitis B

Published:2014-09-04 Issue:12 Volume:59 Page:1714-1723
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Xie Q.,Zhou H.,Bai X.,Wu S.,Chen J.-J.,Sheng J.,Xie Y.,Chen C.,Chan H. L.-Y.,Zhao M.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Reference30 articles.

1. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

2. Chronic hepatitis B: Update 2009

3. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

4. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection

5. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction model for hepatitis B e antigen seroconversion in chronic hepatitis B with peginterferon-alfa treated based on a response-guided therapy strategy;World Journal of Hepatology;2024-03-27

2. Bictegravir/Emtricitabine/Tenofovir Alafenomide for the Treatment of HIV/Hepatitis B Virus Co-infection in Patients with Cancer and Transplant Recipients;Infectious Diseases;2023

3. Pegylated interferon‐α‐2b combined with tenofovir disoproxil fumarate, granulocyte‐macrophage colony‐stimulating factor, and hepatitis B vaccine treatment for naïve HBeAg‐positive chronic hepatitis B patients: A prospective, multicenter, randomized controlled study;Journal of Medical Virology;2022-07-19

4. A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients;Journal of Clinical and Experimental Hepatology;2022-05

5. Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients;Hepatology Research;2022-04-12